Tuesday, 18 December, 2018

Cancer 'Vaccine' Wiped Out Tumors In Mice, Scientists Say

Cancer 'Vaccine' Wiped Out Tumors In Mice, Scientists Say Cancer 'Vaccine' Wiped Out Tumors In Mice, Scientists Say
Theresa Hayes | 08 February, 2018, 06:39

A cancer "vaccine" is gaining national attention after Stanford researchers found that it eliminates tumors in mice.

An incredible breakthrough in cancer research was announced last week by researchers at the Stanford University School of Medicine when a cancer "vaccine" successfully eliminated tumors in mice.

The findings were published this week and are getting a lot of attention. The study added that although the cancer returned in three mice, the tumors regressed after a second treatment.

The study says this approach could work for many types of cancer and provide a rapid and relatively low-priced cancer therapy.

According to Stanford Medicine, researchers used a one-time application of two agents on mice and saw the elimination of tumors all over the body. "In the mice, we saw wonderful, body-wide effects, including the elimination of tumours all over the animal", said Dr Levy, a Professor of Oncology.

Out of the two immune "agents" used in the study, published in the journal Science Translational Medicine, one has already been approved for use in humans and the second is now involved in a lymphoma treatment trial.

The boosters reinvigorated the T-cells, allowing the cells to destroy the tumors and related cancer that had metastasized throughout the mice.

It's also unlikely to cause adverse side effects often seen with other immune stimulation, according to researchers. Levy looks forward to a future where doctors administer the two agents into the solid tumors in patients before surgically removing cancer to prevent metastases or cancer recurrence.

A clinical trial was launched in January to test the effect of the treatment in patients with lymphoma. The study was also successful in mice that had breast, colon and melanoma tumors.

"I don't think there's a limit to the type of tumor we could potentially treat as long as it has been infiltrated by the immune system", Levy said.

Levy is hopeful this treatment will be successful on multiple types of tumors.